Lucid Capital Initiates Quoin Pharmaceuticals(QNRX.US) With Buy Rating, Announces Target Price $30

Moomoo NewsMay 4 06:31 ET · Ratings

Quoin Pharmaceuticals Initiated With a Buy at Lucid Capital

TipRanksMay 4 06:11 ET · Ratings

Quoin Pharmaceuticals (QNRX.US) will release its earnings report before the market opens on May 7.

$Quoin Pharmaceuticals(QNRX.US)$ is scheduled to release its earnings report before the market opens on May 7. Investors are advised to stay tuned. Niuniu Reminder: 1. There are no mandatory regulations regarding the division of accounting years for companies listed in Hong Kong or the United States; it is entirely determined by the company itself. Therefore, each earnings reporting period can serve as the end date for the company’s annual report without aligning with the calendar year as the fiscal year. 2. Generally, the company will hold an earnings call on or around the aforementioned earnings release date. The management team will discuss and explain the financial data and operational performance of the latest quarter during this call and engage with investors.

Moomoo NewsMay 1 21:00 ET

Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026

Quoin PharmaceuticalsApr 30 00:00 ET

Quoin Pharmaceuticals Announces Multi-Study Initiative for QRX009 Targeting Pachyonychia Congenita, Gorlin Syndrome, and Tuberous Sclerosis Complex

Quiver QuantitativeApr 28 12:10 ET

Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs

Quoin PharmaceuticalsApr 28 00:00 ET